Future Products

Ohmedics was spun out of the University of Strathclyde in 2009 and has retained close, collaborative links with the University. With a unique portfolio of granted and pending patents suitable for mobile diagnostic and monitoring systems and our strategic plans for telehealth and advanced wound care we have a number of products in development. These include:

Wearable Sensors - Transdermal sensors

With pending IP on a revolutionary ‘on skin’ calibration method for transdermal sensing of molecules and ions we have clinically investigated the transdermal detection of glucose, lactate, potassium and Vitamin D. We are partnered with the Royal Hospital for Sick Children in Glasgow, the University of Strathclyde, and supported by Yorkhill Children’s Charity, to research and develop transdermal systems for neo-natal monitoring of lactate. In our partner laboratory at the University of Strathclyde (Medical Diagnostic Devices – led by Prof Patricia Connolly) a prototype Bluetooth wearable monitor for tracking sweat levels and ion content during exercise is currently being tested.

here for BBC news item on wearable sensor.

Lung infection detection in the home and clinic

In the UK alone respiratory disease costs the NHS and society £6.6 billion per annum. Major respiratory diseases include tuberculosis, pneumonia, asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. We are using our patented bactreial technology to develop a system for disease prevention and proactive management of health and chronic conditions in the field of lung infection. The home use (or GP surgery based) small device and system we are developing will allow earlier and better detection and diagnosis of lung infection leading to marked improvements in patient outcomes including reduced admissions to hospital and less prescribing of unnecessary antibiotics. The device will be used by a patient at home on a regular basis or in a clinic and will bluetooth to a patient, doctor or carer's mobile phone for rapid reporting of lung status.
An early proof of concept project has been completed for Cystic Fibrosis lung infection monitoring with the support of Gilead Sciences and the EPSRC Impact Accelerator Programme, in partnership with the University of Strathclyde. We have now been awarded a three year grant by Innovate UK to fully develop the system for home use for a wide range of lung infections and to support a range of chronic lung disease patient groups. We expect to release the device to the market in 2018.

Bacterial Sensors for Wound Dressings

Our patented bacterial detection technology allows unique electrical signatures to be determined from the presence of different types of bacteria. We have ongoing research into the development of an ‘in dressing’ sensor that will electrically interrogate the wound environment for the presence and growth of bacteria. This technology may have applications in other medical and industrial sectors and we welcome inquiries from established commercial bodies who may wish to access this technology.

Disposable pH Sensors

Wound exudate pH could be an important indicator of the wound healing status but it has yet to be researched on a sufficient scale to draw sound conclusions. This has been due to the difficulty of obtaining rapid and reliable measurements. We have developed with Strathclyde a disposable printed pH sensor to facilitate this which will be tested in Hamad Medical Corporation, Doha in a collaborative international research project funded by the Qatar National Research Fund.

Back to Products page

We are located at:

Ohmedics Ltd.

50 Richmond Street
G1 1XP
Tel. No. +44(0)141-303-8385

Contact us

If you have any queries or would like further information, please contact us:


Tel. No.  +44 (0)141-303-8385


email: info@ohmedics.com


Or use our contact form here.


Print Print | Sitemap
Created by UCS